Ducommun DCO Commercial aerospace — Net Revenues

Other product segments

Similar metrics at other companies

ANIPRare Disease total net revenues — Net Revenues

$135.84M+30.7%

ANIPOther generic revenues — Net Revenues

$1.61M-59.0%

ANIPBrands — Net Revenues

$11.81M-10.5%

ANIPGenerics and Other total net revenues — Net Revenues

$100.66M+6.8%

ANIPRare Disease and Brands total net revenues — Net Revenues

$165.39M+41.2%

ANIPCortrophin Gel — Net Revenues

$117.13M+43.5%

FAQ

What is Ducommun's commercial aerospace — net revenues?

Ducommun (DCO) reported commercial aerospace — net revenues of $89.42M in Q2 2026.

How has Ducommun's commercial aerospace — net revenues changed year-over-year?

Ducommun's commercial aerospace — net revenues increased by 15.5% year-over-year, from $77.4M to $89.42M.

What is the long-term trend for Ducommun's commercial aerospace — net revenues?

Over 4 years (2021 to 2025), Ducommun's commercial aerospace — net revenues has grown at a 18.6% compound annual growth rate (CAGR), from $155.73M to $307.84M.

What does commercial aerospace — net revenues mean?

This metric represents the total gross sales generated from products and services provided to the commercial aerospace market segment after accounting for returns, allowances, and discounts. It serves as a primary indicator of the company's market penetration and demand within the civil aviation sector. Tracking this figure helps investors assess the scale and revenue contribution of commercial aerospace activities relative to the company's total business portfolio.